Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 213

1.

Non-invasive Detection of Antibodies to Human T-lymphotropic Viruses 1 and 2 using Oral Fluid.

Woo T, Rosadas C, Ijaz S, Dicks S, Tosswill JHC, Tedder RS, Taylor GP.

J Clin Microbiol. 2019 Oct 9. pii: JCM.01179-19. doi: 10.1128/JCM.01179-19. [Epub ahead of print]

PMID:
31597746
2.

Resolution by deep sequencing of a dual hepatitis E virus infection transmitted via blood components.

Ledesma J, Williams D, Stanford FA, Hewitt PE, Zuckerman M, Bansal S, Dhawan A, Mbisa JL, Tedder R, Ijaz S.

J Gen Virol. 2019 Oct 8. doi: 10.1099/jgv.0.001302. [Epub ahead of print]

PMID:
31592753
3.

Standardising surveillance of hepatitis E virus infection in the EU/EEA: A review of national practices and suggestions for the way forward.

Adlhoch C, Manďáková Z, Ethelberg S, Epštein J, Rimhanen-Finne R, Figoni J, Baylis SA, Faber M, Mellou K, Murphy N, O'Gorman J, Tosti ME, Ciccaglione AR, Hofhuis A, Zaaijer H, Lange H, de Sousa R, Avellón A, Sundqvist L, Said B, Ijaz S.

J Clin Virol. 2019 Sep 19;120:63-67. doi: 10.1016/j.jcv.2019.09.005. [Epub ahead of print]

PMID:
31590112
4.

Genetic Analysis of Tyrosinemia Type 1 and Fructose-1, 6 Bisphosphatase Deficiency Affected Pakistani Cohorts.

Yasir Zahoor M, Cheema HA, Ijaz S, Fayyaz Z.

Fetal Pediatr Pathol. 2019 Oct 4:1-11. doi: 10.1080/15513815.2019.1672224. [Epub ahead of print]

PMID:
31584309
5.

Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) - a natural experiment (protocol).

Hickman M, Dillon JF, Elliott L, De Angelis D, Vickerman P, Foster G, Donnan P, Eriksen A, Flowers P, Goldberg D, Hollingworth W, Ijaz S, Liddell D, Mandal S, Martin N, Beer LJZ, Drysdale K, Fraser H, Glass R, Graham L, Gunson RN, Hamilton E, Harris H, Harris M, Harris R, Heinsbroek E, Hope V, Horwood J, Inglis SK, Innes H, Lane A, Meadows J, McAuley A, Metcalfe C, Migchelsen S, Murray A, Myring G, Palmateer NE, Presanis A, Radley A, Ramsay M, Samartsidis P, Simmons R, Sinka K, Vojt G, Ward Z, Whiteley D, Yeung A, Hutchinson SJ.

BMJ Open. 2019 Sep 24;9(9):e029538. doi: 10.1136/bmjopen-2019-029538.

6.

Causes, Trends, and Predictors of 90-Day Readmissions After Spontaneous Coronary Artery Dissection (from A Nationwide Readmission Database).

Virk HUH, Tripathi B, Kumar V, Lakhter V, Khan MS, Ijaz SH, Dean S, Gupta S, Sharma P, Mishra R, George JC, Gopalan R, Zidar D, Janzer S.

Am J Cardiol. 2019 Aug 9. pii: S0002-9149(19)30889-6. doi: 10.1016/j.amjcard.2019.07.058. [Epub ahead of print]

PMID:
31551116
7.

Mapping of IDUA gene variants in Pakistani patients with mucopolysaccharidosis type 1.

Zahoor MY, Cheema HA, Ijaz S, Anjum MN, Ramzan K, Bhinder MA.

J Pediatr Endocrinol Metab. 2019 Sep 2. pii: /j/jpem.ahead-of-print/jpem-2019-0188/jpem-2019-0188.xml. doi: 10.1515/jpem-2019-0188. [Epub ahead of print]

PMID:
31473686
8.

Exposure of BPA and its alternatives like BPB, BPF, and BPS impair subsequent reproductive potentials in adult female Sprague Dawley rats.

Ijaz S, Ullah A, Shaheen G, Jahan S.

Toxicol Mech Methods. 2019 Sep 13:1-13. doi: 10.1080/15376516.2019.1652873. [Epub ahead of print]

PMID:
31424294
9.

Phenolic, flavonoid content and radical scavenging activity of Smilax China with its inhibitory potential against clinically important enzymes.

Ahmad HI, Shoaib Khan HM, Akhtar N, Ijaz S.

Nat Prod Res. 2019 Aug 6:1-6. doi: 10.1080/14786419.2019.1648463. [Epub ahead of print]

PMID:
31385538
10.

Modulated Zika virus NS1 conjugate offers advantages for accurate detection of Zika virus specific antibody in double antigen binding and Ig capture enzyme immunoassays.

Tedder RS, Dicks S, Ijaz S, Santiago de Souza NC, Vincente de Paula A, Levy F, Medialdea-Carrera R, Levi JE, Pannuti CS, Carvalho de Sequeira P, Brown DWG, Ushiro Lumb I.

PLoS One. 2019 Aug 2;14(8):e0215708. doi: 10.1371/journal.pone.0215708. eCollection 2019.

11.

Interventions for preventing obesity in children.

Brown T, Moore TH, Hooper L, Gao Y, Zayegh A, Ijaz S, Elwenspoek M, Foxen SC, Magee L, O'Malley C, Waters E, Summerbell CD.

Cochrane Database Syst Rev. 2019 Jul 23;7:CD001871. doi: 10.1002/14651858.CD001871.pub4.

PMID:
31332776
12.

Transdermal patches: Design and current approaches to painless drug delivery.

Al Hanbali OA, Khan HMS, Sarfraz M, Arafat M, Ijaz S, Hameed A.

Acta Pharm. 2019 Jun 1;69(2):197-215. doi: 10.2478/acph-2019-0016. Review.

PMID:
31259729
13.

Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff.

Verbeek JH, Rajamaki B, Ijaz S, Tikka C, Ruotsalainen JH, Edmond MB, Sauni R, Kilinc Balci FS.

Cochrane Database Syst Rev. 2019 Jul 1;7:CD011621. doi: 10.1002/14651858.CD011621.pub3.

PMID:
31259389
14.

Epidemiology of Hepatitis E in England and Wales: A 10-Year Retrospective Surveillance Study, 2008-2017.

Oeser C, Vaughan A, Said B, Ijaz S, Tedder R, Haywood B, Warburton F, Charlett A, Elson R, Morgan D.

J Infect Dis. 2019 Jul 31;220(5):802-810. doi: 10.1093/infdis/jiz207.

PMID:
31107958
15.

Hemorrhagic cardiac tamponade associated with Apixaban: A case report and systematic review of literature.

Asad ZUA, Ijaz SH, Chaudhary AMD, Khan SU, Pakala A.

Cardiovasc Revasc Med. 2019 Apr 4. pii: S1553-8389(19)30228-3. doi: 10.1016/j.carrev.2019.04.002. [Epub ahead of print]

PMID:
31088720
16.

Convalescent plasma therapy for persistent hepatitis E virus infection.

Ankcorn M, Gallacher J, Ijaz S, Taha Y, Harvala H, Maclennan S, Thomson EC, Davis C, Singer JB, da Silva Filipe A, Smollett K, Niebel M, Semple MG, Tedder RS, McPherson S.

J Hepatol. 2019 Aug;71(2):434-438. doi: 10.1016/j.jhep.2019.04.008. Epub 2019 May 8. No abstract available.

PMID:
31075322
17.

Causes of death among persons diagnosed with hepatitis C infection in the pre- and post-DAA era in England: A record linkage study.

Simmons R, Ireland G, Ijaz S, Ramsay M, Mandal S; National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Blood Borne, Sexually Transmitted Infections.

J Viral Hepat. 2019 Jul;26(7):873-880. doi: 10.1111/jvh.13096. Epub 2019 Apr 23.

PMID:
30896055
18.

Seroprevalence of HCV, HBV and HIV in two inner-city London emergency departments.

Cieply L, Simmons R, Ijaz S, Kara E, Rodger A, Rosenberg W, McGuinness A, Mbisa JL, Ledesma J, Ohemeng-Kumi N, Dicks S, Potts H, Lattimore S, Mandal S.

Epidemiol Infect. 2019 Jan;147:e145. doi: 10.1017/S0950268819000360.

19.

Hepatitis E virus in blood donors in England, 2016 to 2017: from selective to universal screening.

Harvala H, Hewitt PE, Reynolds C, Pearson C, Haywood B, Tettmar KI, Ushiro-Lumb I, Brailsford SR, Tedder R, Ijaz S.

Euro Surveill. 2019 Mar;24(10). doi: 10.2807/1560-7917.ES.2019.24.10.1800386.

20.

New oral and topical approaches for the treatment of melasma.

Grimes PE, Ijaz S, Nashawati R, Kwak D.

Int J Womens Dermatol. 2018 Nov 20;5(1):30-36. doi: 10.1016/j.ijwd.2018.09.004. eCollection 2019 Feb.

21.

Response to: 'Chronic genotype 1 hepatitis E infection from immunosuppression for ileo-colonic Crohn's disease'.

Ankcorn M, Haywood B, Tedder R, Ijaz S.

Oxf Med Case Reports. 2019 Feb 16;2019(2):omy125. doi: 10.1093/omcr/omy125. eCollection 2019 Feb. No abstract available.

22.

Characterising the risk of Hepatitis E virus infection in haematological malignancies: a UK prospective prevalence study.

Ankcorn MJ, Fox TA, Ijaz S, Nicholas C, Houston E, Longair I, Suri D, Mattes FM, Walker JL, Tedder RS, Sekhar M.

Br J Haematol. 2019 Jul;186(1):191-195. doi: 10.1111/bjh.15796. Epub 2019 Feb 15. No abstract available.

PMID:
30768677
23.

Folate-Functionalized Thiomeric Nanoparticles for Enhanced Docetaxel Cytotoxicity and Improved Oral Bioavailability.

Sajjad M, Khan MI, Naveed S, Ijaz S, Qureshi OS, Raza SA, Shahnaz G, Sohail MF.

AAPS PharmSciTech. 2019 Jan 15;20(2):81. doi: 10.1208/s12249-019-1297-z.

PMID:
30645705
24.

Workplace interventions for reducing sitting at work.

Shrestha N, Kukkonen-Harjula KT, Verbeek JH, Ijaz S, Hermans V, Pedisic Z.

Cochrane Database Syst Rev. 2018 Dec 17;12:CD010912. doi: 10.1002/14651858.CD010912.pub5.

PMID:
30556590
25.

HPLC profiling of Mimosa pudica polyphenols and their non-invasive biophysical investigations for anti-dermatoheliotic and skin reinstating potential.

Ijaz S, Shoaib Khan HM, Anwar Z, Talbot B, Walsh JJ.

Biomed Pharmacother. 2019 Jan;109:865-875. doi: 10.1016/j.biopha.2018.10.089. Epub 2018 Nov 5.

26.

Relationship Between Thyroid Hormone Levels and Mean Platelet Count and Volume: Quantitative Assessment.

Ijaz SH, Jamal SM, Qayyum R.

Cureus. 2018 Oct 8;10(10):e3421. doi: 10.7759/cureus.3421.

27.

A comparison of two biological markers of recent hepatitis C virus (HCV) infection: implications for the monitoring of interventions and strategies to reduce HCV transmission among people who inject drugs.

Hope VD, Harris RJ, Vickerman P, Platt L, Shute J, Cullen KJ, Ijaz S, Mandal S, Ncube F, Desai M, Parry JV.

Euro Surveill. 2018 Nov;23(47). doi: 10.2807/1560-7917.ES.2018.23.47.1700635.

28.

Wide spectrum of referral routes for acute hepatitis E infections.

Rogers B, Haywood B, David J, Patel A, Ijaz S, Tang JW.

J Infect. 2019 Mar;78(3):249-259. doi: 10.1016/j.jinf.2018.11.002. Epub 2018 Nov 22. No abstract available.

PMID:
30471300
29.

Zebrafish Models of Neurodevelopmental Disorders: Past, Present, and Future.

Sakai C, Ijaz S, Hoffman EJ.

Front Mol Neurosci. 2018 Aug 29;11:294. doi: 10.3389/fnmol.2018.00294. eCollection 2018. Review.

30.

The effects of changes to the built environment on the mental health and well-being of adults: Systematic review.

Moore THM, Kesten JM, López-López JA, Ijaz S, McAleenan A, Richards A, Gray S, Savović J, Audrey S.

Health Place. 2018 Sep;53:237-257. doi: 10.1016/j.healthplace.2018.07.012. Epub 2018 Sep 6.

31.

Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews.

Ijaz S, Bolea B, Davies S, Savović J, Richards A, Sullivan S, Moran P.

BMC Psychiatry. 2018 Sep 3;18(1):275. doi: 10.1186/s12888-018-1848-y. Review.

32.

Phytocosmeceutical formulation development, characterization and its in-vivo investigations.

Mohammad IS, Naveed M, Ijaz S, Shumzaid M, Hassan S, Muhammad KS, Rasool F, Akhtar N, Ishaq HM, Khan HMS.

Biomed Pharmacother. 2018 Nov;107:806-817. doi: 10.1016/j.biopha.2018.08.024. Epub 2018 Aug 22.

PMID:
30142542
33.

Absence of Persistent Hepatitis E Virus Infection in Antibody-Deficient Patients Is Associated With Transfer of Antigen-Neutralizing Antibodies From Immunoglobulin Products.

Ankcorn M, Moreira F, Ijaz S, Symes A, Buckland MS, Workman S, Warburton F, Tedder RS, Lowe DM.

J Infect Dis. 2019 Jan 7;219(2):245-253. doi: 10.1093/infdis/jiy504.

PMID:
30137432
34.

Hepatitis E infection in stem cell and solid organ transplantpatients: A cross-sectional study: The importance of HEV RNA screening in peri-transplant period.

Reekie I, Irish D, Ijaz S, Fox T, Bharucha T, Griffiths P, Thorburn D, Harber M, MacKinnon S, Sekhar M.

J Clin Virol. 2018 Oct;107:1-5. doi: 10.1016/j.jcv.2018.07.011. Epub 2018 Jul 29.

PMID:
30099145
35.

Diagnostic utility of hepatitis E virus antigen-specific ELISA versus PCR testing in a cohort of post liver transplant patients in a large university hospital.

Soothill G, Hessey S, Erotocritou M, Griffiths P, Ijaz S, Thorburn D, Ankcorn M, Irish D.

J Clin Virol. 2018 Sep;106:44-48. doi: 10.1016/j.jcv.2018.07.007. Epub 2018 Jul 20.

PMID:
30053748
36.

Toward Systematic Screening for Persistent Hepatitis E Virus Infections in Transplant Patients.

Ankcorn MJ, Ijaz S, Poh J, Elsharkawy AM, Smit E, Cramb R, Ravi S, Martin K, Tedder R, Neuberger J.

Transplantation. 2018 Jul;102(7):1139-1147. doi: 10.1097/TP.0000000000002097.

PMID:
29953421
37.

Flaxseed Can Reduce Hypoxia-Induced Damages in Rat Testes.

Poorhassan M, Navae F, Mahakizadeh S, Bazrafkan M, Nikmehr B, Abolhassani F, Ijaz S, Yamini N, Dashti N, Mehrannia K, Hassanzadeh GH, Akbari M.

Int J Fertil Steril. 2018 Jun;12(3):235-241. doi: 10.22074/ijfs.2018.5298. Epub 2018 Jun 20.

38.

Workplace interventions for reducing sitting at work.

Shrestha N, Kukkonen-Harjula KT, Verbeek JH, Ijaz S, Hermans V, Pedisic Z.

Cochrane Database Syst Rev. 2018 Jun 20;6:CD010912. doi: 10.1002/14651858.CD010912.pub4. Review. Update in: Cochrane Database Syst Rev. 2018 Dec 17;12:CD010912.

39.

Plant derived anticancer agents: A green approach towards skin cancers.

Ijaz S, Akhtar N, Khan MS, Hameed A, Irfan M, Arshad MA, Ali S, Asrar M.

Biomed Pharmacother. 2018 Jul;103:1643-1651. doi: 10.1016/j.biopha.2018.04.113. Epub 2018 May 7. Review.

PMID:
29864953
40.

The incubation period of hepatitis E genotype 1: insights from pooled analyses of travellers.

Azman AS, Ciglenecki I, Oeser C, Said B, Tedder RS, Ijaz S.

Epidemiol Infect. 2018 Sep;146(12):1533-1536. doi: 10.1017/S0950268818001097. Epub 2018 May 24.

41.

Psychological therapies for treatment-resistant depression in adults.

Ijaz S, Davies P, Williams CJ, Kessler D, Lewis G, Wiles N.

Cochrane Database Syst Rev. 2018 May 14;5:CD010558. doi: 10.1002/14651858.CD010558.pub2. Review.

42.

Hepatitis B Virus Immunization and Neonatal Acquisition of Persistent Infection in England and Wales.

May S, Mandal S, Keel P, Haywood B, Ngui SL, Ramsay M, Tedder RS, Ijaz S.

J Infect Dis. 2018 Jul 24;218(5):726-733. doi: 10.1093/infdis/jiy209.

PMID:
29688415
43.

Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone.

Tedder RS, Samuel D, Dicks S, Scott JT, Ijaz S, Smith CC, Adaken C, Cole C, Baker S, Edwards T, Kamara P, Kargbo O, Niazi S, Nwakanma D, d'Alessandro U, Burch G, Doughty H, Brown CS, Andrews N, Glynn JR, van Griensven J; Ebola_CP Consortium Investigators, Pollakis G, Paxton WA, Semple MG.

Transfusion. 2018 May;58(5):1289-1298. doi: 10.1111/trf.14580. Epub 2018 Mar 23.

44.
45.

Transfusion-transmitted hepatitis B virus (HBV) infection from an individual-donation nucleic acid (ID-NAT) non-reactive donor.

O'Flaherty N, Ushiro-Lumb I, Pomeroy L, Ijaz S, Boland F, De Gascun C, Fitzgerald J, O'Riordan J.

Vox Sang. 2018 Apr;113(3):300-303. doi: 10.1111/vox.12633. Epub 2018 Feb 14.

PMID:
29441587
46.

Stage of disease in hepatitis B virus infection in Zambian adults is associated with large cell change but not well defined using classic biomarkers.

Nsokolo B, Kanunga A, Sinkala E, Zyambo K, Kumwenda D, Chama D, Muyinda G, Vinikoor M, Ijaz S, Tedder R, Elmdaah AKA, Jones M, Chiluba C, Mudenda V, Goldin RD, Foster G, Kelly P.

Trans R Soc Trop Med Hyg. 2017 Sep 1;111(9):425-432. doi: 10.1093/trstmh/trx077.

47.

Quality of family relationships and outcomes of dementia: a systematic review.

Edwards HB, Ijaz S, Whiting PF, Leach V, Richards A, Cullum SJ, Cheston RI, Savović J.

BMJ Open. 2018 Jan 21;8(1):e015538. doi: 10.1136/bmjopen-2016-015538. Review.

48.

Interventions for preventing or treating malnutrition in homeless problem-drinkers: a systematic review.

Ijaz S, Thorley H, Porter K, Fleming C, Jones T, Kesten J, Mamluk L, Richards A, Marques EMR, Savović J.

Int J Equity Health. 2018 Jan 16;17(1):8. doi: 10.1186/s12939-018-0722-3. Review.

49.

Establishing the cascade of care for hepatitis C in England-benchmarking to monitor impact of direct acting antivirals.

Simmons R, Ireland G, Irving W, Hickman M, Sabin C, Ijaz S, Ramsay M, Lattimore S, Mandal S.

J Viral Hepat. 2018 May;25(5):482-490. doi: 10.1111/jvh.12844. Epub 2018 Mar 15.

PMID:
29239130
50.

Confirmation of specificity of reactivity in a solid phase ELISA for the detection of hepatitis E viral antigen improves utility of the assay.

Ankcorn MJ, Ijaz S, Haywood B, Neuberger J, Elsharkawy AM, Maggs J, Tedder RS.

J Virol Methods. 2018 Feb;252:42-48. doi: 10.1016/j.jviromet.2017.11.007. Epub 2017 Nov 20.

PMID:
29158182

Supplemental Content

Support Center